297 related articles for article (PubMed ID: 30926784)
1. Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents.
Clough TJ; Jiang L; Wong KL; Long NJ
Nat Commun; 2019 Mar; 10(1):1420. PubMed ID: 30926784
[TBL] [Abstract][Full Text] [Related]
2. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
3. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
[TBL] [Abstract][Full Text] [Related]
4. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the high-field relaxivity by self-assembling of macrocyclic Gd(III) complexes.
Lawson D; Barge A; Terreno E; Parker D; Aime S; Botta M
Dalton Trans; 2015 Mar; 44(11):4910-7. PubMed ID: 25411928
[TBL] [Abstract][Full Text] [Related]
6. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ
Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175
[TBL] [Abstract][Full Text] [Related]
7. Highly relaxing gadolinium based MRI contrast agents responsive to Mg2+ sensing.
Abada S; Lecointre A; Elhabiri M; Esteban-Gómez D; Platas-Iglesias C; Tallec G; Mazzanti M; Charbonnière LJ
Chem Commun (Camb); 2012 Apr; 48(34):4085-7. PubMed ID: 22430859
[TBL] [Abstract][Full Text] [Related]
8. Coordination chemistry of amide-functionalised tetraazamacrocycles: structural, relaxometric and cytotoxicity studies.
Martinelli J; Balali-Mood B; Panizzo R; Lythgoe MF; White AJ; Ferretti P; Steinke JH; Vilar R
Dalton Trans; 2010 Nov; 39(42):10056-67. PubMed ID: 20877892
[TBL] [Abstract][Full Text] [Related]
9. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
Caravan P
Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
[TBL] [Abstract][Full Text] [Related]
10. A low-molecular-weight ditopic MRI probe for ratiometric sensing of zwitterionic amino acid neurotransmitters.
Toljić Đ; Angelovski G
Chem Commun (Camb); 2019 Oct; 55(79):11924-11927. PubMed ID: 31528965
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging.
Zu G; Kuang Y; Dong J; Cao Y; Zhang T; Liu M; Luo L; Pei R
Curr Med Chem; 2018; 25(25):2910-2937. PubMed ID: 28292237
[TBL] [Abstract][Full Text] [Related]
13. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
Datta A; Raymond KN
Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
[TBL] [Abstract][Full Text] [Related]
14. Interaction of macrocyclic gadolinium-based MR contrast agents with Type I collagen. Equilibrium and kinetic studies.
Guidolin N; Travagin F; Giovenzana GB; Vágner A; Lotti S; Chianale F; Brücher E; Maisano F; Kirchin MA; Tedoldi F; Giorgini A; Colombo Serra S; Baranyai Z
Dalton Trans; 2020 Nov; 49(42):14863-14870. PubMed ID: 33073806
[TBL] [Abstract][Full Text] [Related]
15. Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.
Polasek M; Caravan P
Inorg Chem; 2013 Apr; 52(7):4084-96. PubMed ID: 23517079
[TBL] [Abstract][Full Text] [Related]
16. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-based contrast agents for magnetic resonance cancer imaging.
Zhou Z; Lu ZR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):1-18. PubMed ID: 23047730
[TBL] [Abstract][Full Text] [Related]
18. Stability of linear and macrocyclic gadolinium based contrast agents.
Schmitt-Willich H
Br J Radiol; 2007 Jul; 80(955):581-2; author reply 584-5. PubMed ID: 17704318
[No Abstract] [Full Text] [Related]
19. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
Hermann P; Kotek J; Kubícek V; Lukes I
Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
[TBL] [Abstract][Full Text] [Related]
20. Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent.
Reale G; Calderoni F; Ghirardi T; Porto F; Illuminati F; Marvelli L; Martini P; Uccelli L; Tonini E; Del Bianco L; Spizzo F; Capozza M; Cazzola E; Carnevale A; Giganti M; Turra A; Esposito J; Boschi A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
